直肠癌放射治疗研究进展
Advances in Radiotherapy for Locally Advanced Rectal Cancer
DOI: 10.12677/ACM.2018.81011, PDF,   
作者: 纪晓萌：青岛大学医学院，山东 青岛；韩真真, 袁胜利*：青岛市市立医院肿瘤科，山东 青岛
关键词: 直肠肿瘤；放射治疗；进展期；同步放化疗；Rectal Neoplasms； Radiotherapy； Advanced； Chemoradiotherapy
摘要: 放射治疗作为局部晚期直肠癌综合治疗的一个重要组成部分，联合手术治疗可降低局部复发率，提高患者总生存率。近年来多项研究对如何进一步提高放疗疗效、放疗方式、T3N0M0患者是否都需要放疗及放疗与手术时间间隔等问题进行了探索，本篇综述除讨论放疗的基本作用，并对上述研究热点做出总结分析。
Abstract: Radiotherapy (RT) is an important part of the comprehensive treatment of locally advanced rectal cancer, which reduces the local recurrence rate in combination with surgery and improves survival of rectal cancer. The timing of radiotherapy, the way of radiotherapy, the needs of radiotherapy for T3N0M0 rectal cancer, the timing of surgery are summarized as follows. This review will discuss not only the basic role of RT but also the associated with controversial issues in detail.
文章引用：纪晓萌, 韩真真, 袁胜利. 直肠癌放射治疗研究进展[J]. 临床医学进展, 2018, 8(1): 59-63. https://doi.org/10.12677/ACM.2018.81011

参考文献

[1] Siegel, R.L., Miller, K.D., Fedewa, S.A., Ahnen, D.J., Meester, R.G., Barzi, A., et al. (2017) Colorectal Cancer Statistics, 2017. Ca A Cancer Journal for Clinicians, 67, 177.
[Google Scholar] [CrossRef] [PubMed]
[2] 刘鲁迎, 朱远. cT3期直肠癌是否都需要放疗[J]. 中华结直肠疾病电子杂志, 2015(4): 21-23.
[3] Song, J.H., Jeong, J.U., Lee, J.H., Kim, S.H., Cho, H.M., Um, J.W., et al. (2017) Preoperative Chemoradiotherapy versus Postoperative Chemoradiotherapy for Stage ii-iii Resectable Rectal Cancer: A Me-ta-Analysis of Randomized Controlled Trials. Radiation Oncology Journal, 35, 198.
[Google Scholar] [CrossRef] [PubMed]
[4] Listed, N. (1990) Nih Consensus Conference. Adjuvant Therapy for Patients with Colon and Rectal Cancer. Jama the Journal of the American Medical Association, 264, 1444-1450.
[Google Scholar] [CrossRef] 
[5] Metzger, U. (1990) Adjuvant Therapy for Colon and Rectal Cancer NIH Consensus Development Conference. European Journal of Cancer, 26, 753-755.
[Google Scholar] [CrossRef] 
[6] Trial, S.R.C., Cedermark, B., Dahlberg, M., Glimelius, B., Påhlman, L. and Rutqvist, L.E., et al. (1997) Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer. New England Journal of Medicine, 336, 980.
[Google Scholar] [CrossRef] 
[7] Heald, R.J. and Ryall, R.D. (1986) Recurrence and Survival after total Mesorectal Excision for Rectal Cancer. Lancet (London, England), 1, 1479.
[Google Scholar] [CrossRef] 
[8] ElMasry, S. (2017) Laparoscopic Total Mesorectal Excision for Rectal Cancer: Video Vignette. Colorectal Disease, 19.
[Google Scholar] [CrossRef] [PubMed]
[9] Kapiteijn, E. (2001) Preoperative Radiotherapy Combined with total Mesorectal Excision for Resectable Rectal Cancer. New England Journal of Medicine, 177, 682.
[Google Scholar] [CrossRef] 
[10] Bernhoff, R., Martling, A., Sjövall, A., Granath, F., Hohenberger, W. and Holm, T. (2015) Improved Survival after an Educational Project on Colon Cancer Management in the County of Stockholm—A Population Based Cohort Study. European Journal of Surgical Oncology, 41, 1479-1484.
[11] Van, G.W., Marijnen, C.A., Nagtegaal, I.D., Kranenbarg, E.M., Putter, H., Wiggers, T., et al. (2011) Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer: 12-Year Follow-Up of the Multicentre, Randomised Controlled Tme Trial. Lancet Oncology, 12, 575-582.
[Google Scholar] [CrossRef] 
[12] Martling, A.L., Holm, T., Rutqvist, L.E., Moran, B.J., Heald, R.J. and Cedemark, B. (2000) Effect of a Surgical Training Programme on Outcome of Rectal Cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet, 356, 93-96.
[Google Scholar] [CrossRef] 
[13] Sebag-Montefiore, D., Stephens, R.J., Steele, R., Monson, J., Grieve, R., Khanna, S., Quirke, P., Couture, J., de Metz, C., Myint, A.S., Bessell, E., Griffiths, G., Thompson, L.C. and Parmar, M. (2009) Preoperative Radiotherapy versus Selective Postoperative Chemoradiotherapy in Patients with Rectal Cancer (mrc cr07 and ncic-ctg c016): A Multicentre, Randomised Trial. Lancet, 373, 811.
[Google Scholar] [CrossRef] 
[14] Roh, M.S., Colangelo, L.H., O’Connell, M.J., Yothers, G., Deutsch, M., Allegra, C.J., et al. (2009) Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients with Carcinoma of the Rectum: NSABP R-03. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology, 27, 5124.
[Google Scholar] [CrossRef] 
[15] Park, J.H., Yoon, S.M., Yu, C.S., Kim, J.H., Kim, T.W. and Kim, J.C. (2011) Randomized Phase 3 Trial Comparing Preoperative and Postoperative Chemoradiotherapy with Capecitabine for Locally Advanced Rectal Cancer. Cancer, 117, 3703-3712.
[Google Scholar] [CrossRef] [PubMed]
[16] Sauer, R., Becker, H., Hohenberger, W., Rödel, C., Wittekind, C., Fietkau, R., et al. (2004) Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. The New England Journal of Medicine, 351, 1731-1740.
[Google Scholar] [CrossRef] 
[17] Sauer, R., Liersch, T., Merkel, S., Fietkau, R., Hohenberger, W., Hess, C., et al. (2012) Preoperative versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German cao/aro/aio-94 Randomized Phase III Trial after a Median Follow-Up of 11 Years. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 30, 1926-1933.
[Google Scholar] [CrossRef] 
[18] Bujko, K., Nowacki, M.P., Nasierowska-Guttmejer, A., Michalski, W., Bebenek, M. and Kryj, M. (2006) Long-Term Results of a Randomized Trial Comparing Preoperative Short-Course Radiotherapy with Preoperative Conventionally Fractionated Chemoradiation for Rectal Cancer. British Journal of Surgery, 93, 1215-1223.
[Google Scholar] [CrossRef] [PubMed]
[19] Ngan, S.Y., et al. (2013) Randomized Trial of Short-Course Radiotherapy versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients with T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04. Journal of Clinical Oncology, 30, 3827-3833.
[20] Lee, S.F., Chiang, C.L., Fas, L., Wong, Y.W., Poon, C.M., Fcs, W., et al. (2017) Outcome of Neoadjuvant Chemoradiation in MRI Staged Locally Advanced Rectal Cancer: Retrospective Analysis of 123 Chinese Patients. Journal of the Formosan Medical Association.
[Google Scholar] [CrossRef] [PubMed]
[21] Attia, A., Abdelgawad, M., Fakhry, H., Soliman, A. and Attia, N. (2016) Neoadjuvant Chemoradiotherapy and Chemotherapy in Patients with Locally Advanced Rectal Cancer.
[22] Gunderson, L.L., Sargent, D.J., Tepper, J.E., Wolmark, N., O’Connell, M.J., Begovic, M., et al. (2004) Impact of t and n Stage and Treatment on Survival and Relapse in Adjuvant Rectal Cancer: A Pooled Analysis. Journal of Clinical Oncology, 22, 1785-1796.
[Google Scholar] [CrossRef] 
[23] Francois, Y., Nemoz, C.J., Baulieux, J., Vignal, J., Grandjean, J.P., Partensky, C., et al. (1999) Influence of the Interval between Preoperative Radiation Therapy and Surgery on Downstaging and on the Rate of Sphincter-Sparing Surgery for Rectal Cancer: The Lyon R90-01 Randomized Trial. Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology, 17, 2396.
[Google Scholar] [CrossRef] 
[24] Pach, R., Kulig, J., Richter, P., Gach, T., Szura, M. and Kowalska, T. (2012) Randomized Clinical Trial on Preoperative Radiotherapy 25 gy in Rectal Cancer—Treatment Results at 5-Year Follow-Up. Langenbeck’s Archives of Surgery, 397, 801-807.
[Google Scholar] [CrossRef] [PubMed]

为你推荐